| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PEDIATRICS Vol. 107 No. 1 January 2001, pp. 202-204
AMERICAN ACADEMY OF PEDIATRICS:
Recommended Childhood Immunization Schedule
United States,
January-December 2001
A chart of the Recommended Childhood Immunization Schedule, Unitied States, January - December 2001 as approved by the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) is available for this article in the PDF version of this article.
The annual Recommended
Childhood Immunization Schedule of the American Academy of
Pediatrics (AAP), the Advisory Committee on Immunization Practices
(ACIP) of the Centers for Disease Control and Prevention (CDC), and the
American Academy of Family Physicians (AAFP) is issued in January of
each year.
Since publication of the 2000 Schedule, a major change has
been made. The heptavalent pneumococcal conjugate vaccine (PCV) is
recommended for all children 2 to 23 months of age and also is
recommended for certain other children 24 to 59 months of age who are
at high risk. More information about both PCV and the older
polysaccharide pneumococcal vaccine can be obtained at the AAP Web site
(http://www.aap.org), from Pediatrics,2,3 and
from the ACIP.4 This report provides the year 2001 Schedule, reflecting this change. Some minor changes also
have been placed in the footnotes to the
Schedule.
During the year 2001, it is possible that new recommendations about
these vaccines will be made and that other vaccine products will be
approved by the Food and Drug Administration (FDA). Detailed recommendations for the use of new and current vaccines indicated for use during infancy, childhood, and adolescence are given in the
2000 Red Book,5 AAP (http://www.aap.org) and
ACIP (http://www.cdc.gov/nip) statements on specific vaccines, and the
respective manufacturers' package inserts.
Committee on Infectious Diseases, 2000-2001
Jon S. Abramson, MD, Chairperson
Carol J. Baker, MD
Margaret C. Fisher, MD
Michael A. Gerber, MD
H. Cody Meissner, MD
Dennis L. Murray, MD
Gary D. Overturf, MD
Charles G. Prober, MD
Margaret B. Rennels, MD
Thomas N. Saari, MD
Leonard B. Weiner, MD
Richard J. Whitley, MD
Ex Officio
Larry K. Pickering, MD
Red Book Editor
Liaisons
Lance Chilton, MD
AAP Pediatric Practice Action Group
Scott F. Dowell, MD, MPH
Centers for Disease Control and Prevention
Joanne Embree, MD
Canadian Paediatric Society
Martin G. Myers, MD
National Vaccine Program Office
Walter A. Orenstein, MD
Centers for Disease Control and Prevention
Peter A. Patriarca, MD
Food and Drug Administration
Jeffrey R. Starke, MD
American Thoracic Society
Consultant
Edgar O. Ledbetter, MD
Staff
Joann Kim, MD
![]()
ARTICLE
Top
Article
References
| |
FOOTNOTES |
|---|
The recommendations in this statement do not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.
| |
ABBREVIATIONS |
|---|
AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; CDC, Centers for Disease Control and Prevention; AAFP, American Academy of Family Physicians; PCV, pneumococcal conjugate vaccine; FDA, Food and Drug Administration.
| |
REFERENCES |
|---|
|
|
|---|
-
American Academy of Pediatrics, Committee on Infectious Diseases
Recommended childhood immunization schedule
United States,
January-December. 2000.
Pediatrics
2000;
105:148-151 [Free Full Text] -
Overturf GD,
and the American Academy of Pediatrics, Committee on
Infectious Diseases
Technical report: prevention of pneumococcal
infections, including the use of pneumococcal conjugate and
polysaccharide vaccines and antibiotic prophylaxis.
Pediatrics.
2000;
106:367-376
[Abstract/Free Full Text] -
American Academy of Pediatrics, Committee on Infectious Diseases
Policy statement: prevention of pneumococcal infections, including the
use of pneumococcal conjugate vaccine (Prevnar), and pneumococcal
polysaccharide vaccine, and antibiotic prophylaxis.
Pediatrics
2000;
106:362-366
[Abstract/Free Full Text] - Centers for Disease Control, and Prevention, Advisory Committee on Immunization Practices. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2000;49(RR-9):1-35
- American Academy of Pediatrics. 2000 Red Book: Report of the Committee on Infectious Diseases. Pickering LK, ed. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2000
Pediatrics (ISSN 0031 4005). Copyright ©2001 by the American Academy of Pediatrics
This article has been cited by other articles:
![]() |
A. DERYA, A. NECMI, A. EMRE, and Y. AKGUN DECLINE OF MATERNAL HEPATITIS A ANTIBODIES DURING THE FIRST 2 YEARS OF LIFE IN INFANTS BORN IN TURKEY Am J Trop Med Hyg, August 1, 2005; 73(2): 457 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Lee, J. A. Finkelstein, I. L. Miroshnik, D. Rusinak, J. M. Santoli, S. M. Lett, and T. A. Lieu Pediatricians' Self-reported Clinical Practices and Adherence to National Immunization Guidelines After the Introduction of Pneumococcal Conjugate Vaccine Arch Pediatr Adolesc Med, July 1, 2004; 158(7): 695 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kempe, B. L. Beaty, J. F. Steiner, K. A. Pearson, N. E. Lowery, M. F. Daley, L. A. Crane, and S. Berman The Regional Immunization Registry as a Public Health Tool for Improving Clinical Practice and Guiding Immunization Delivery Policy Am J Public Health, June 1, 2004; 94(6): 967 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. M. Joseph, P. T. Giblin, L. R. Kallenbach, G. Jacobsen, and R. M. Davis Visiting Multiple Sites for Immunization and Vaccine Coverage Levels of Preschool Children in 3 Urban Clinics: Potential Indicator of Record Scatter? Clinical Pediatrics, May 1, 2002; 41(4): 249 - 256. [Abstract] [PDF] |
||||
![]() |
A. Lavin, Y. Ofran, A. Ofran, R. A.M.J. Damoiseaux, E. I. Cantekin, K. L. Sauder, T. Kilpi, J. Eskola, P. H. Makela, and the Finnish Otitis Media Study Group A Pneumococcal Conjugate Vaccine and Acute Otitis Media N. Engl. J. Med., May 31, 2001; 344(22): 1719 - 1720. [Full Text] [PDF] |
||||
![]() |
Committee on Adolescence Health Care for Children and Adolescents in the Juvenile Correctional Care System Pediatrics, April 1, 2001; 107(4): 799 - 803. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||










